Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhixue Quyu Mingmu Tablets versus Compound Xueshuantong Capsules for retinal vein occlusion with fundus hemorrhage
ChiCTR2000033146Phase 4Completed
- Sponsor
- Guang'anmen Hospital
- Start
- Jan 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zhixue quyu mingmu and Fufang Xueshuantong in Vein occlusion (RVO) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Visual effect and Improvement in area of fundus hemorrhage. Started Jan 2014; status: completed.
02
Drugs
zhixue quyu mingmuFufang Xueshuantong
03
Conditions
Vein occlusion (RVO)
Beyond the preview
Go deeper on ChiCTR2000033146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033146.